Serum activin-A as a predictive and prognostic marker in critically ill patients with sepsis

被引:25
|
作者
Lee, Jung-Kyu [1 ]
Choi, Sun Mi [2 ]
Lee, Jinwoo [2 ]
Park, Young Sik [2 ]
Lee, Chang Hoon [2 ]
Yim, Jae-Joon [2 ]
Yoo, Chul-Gyu [2 ]
Kim, Young Whan [2 ]
Han, Sung Koo [2 ]
Lee, Sang-Min [2 ]
机构
[1] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, 101 Daehak Ro, Seoul, South Korea
关键词
activin; acute-phase proteins; biological markers; intensive care units; sepsis; INFLAMMATORY RESPONSE; BINDING-PROTEIN; PROCALCITONIN; FOLLISTATIN; CYTOKINE; BIOMARKERS; CHALLENGE; MORTALITY; PRESEPSIN; SEVERITY;
D O I
10.1111/resp.12751
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objectiveThere are limited data regarding serum activin-A as a biomarker for sepsis. We examined whether serum activin-A concentration could predict sepsis severity and prognosis in the management of critically ill patients with sepsis. MethodsThe subjects were adult patients suspected of having sepsis and admitted to intensive care unit (ICU) from January 2013 to March 2014. Serum activin-A concentration was measured in blood sampled within 48h after ICU admission. The primary and secondary outcomes were the diagnostic value of serum activin-A concentration as a biomarker of sepsis and the prognostic value for predicting the clinical outcomes of sepsis, respectively. ResultsOne hundred and thirty patients who had clinically suspected sepsis were included. Most (66.2%) were male; their median age was 65years, and their Acute Physiology and Chronic Health Evaluation II score was 22.3. Serum activin-A concentration tended to increase with sepsis severity and differed significantly between those with non-sepsis and severe sepsis and between those with severe sepsis and septic shock. The risks of sepsis, severe sepsis and septic shock were significantly higher in patients with a serum activin-A concentration of 251, 319 and 432pg/mL or greater, respectively. Serum activin-A concentration was significantly associated with the Acute Physiology and Chronic Health Evaluation II score, Sequential Organ Failure Assessment score, Charlson comorbidity index and ICU mortality. ConclusionSerum activin-A was a predictor of sepsis severity and a prognostic marker in critically ill patients with sepsis. Serum activin-A concentration in the early phase of sepsis was associated with prognostic indexes on ICU admission and with ICU mortality. We conducted a prospective cohort study of the role of activin-A, a member of the transforming growth factor- superfamily, in patients with sepsis. Increased serum activin-A concentration predicted sepsis severity, correlated with prognostic indexes and predicted intensive care unit mortality.
引用
收藏
页码:891 / 897
页数:7
相关论文
共 50 条
  • [31] Eosinopenia, an early marker of increased mortality in critically ill medical patients
    Abidi, Khalid
    Belayachi, Jihane
    Derras, Youssef
    El Khayari, Mina
    Dendane, Tarek
    Madani, Naoufel
    Khoudri, Ibtissam
    Zeggwagh, Amine Ali
    Abouqal, Redouane
    INTENSIVE CARE MEDICINE, 2011, 37 (07) : 1136 - 1142
  • [32] Composite bioscore is superior to routine biomarkers and established scoring systems in predicting mortality in adult critically ill patients with secondary sepsis
    Rondovic, Goran
    Surbatovic, Maja
    Djordjevic, Dragan
    Stanojevic, Ivan
    Zeba, Snjezana
    Udovicic, Ivo
    Djukic, Snezana
    Eric, Stevan
    Sarac, Momir
    Vojvodic, Danilo
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1173 - 1184
  • [33] Comparison of Two Predictive Models of Sepsis in Critically Ill Patients Based on the Combined Use of Inflammatory Markers
    Li, Xiaoming
    Liu, Chao
    Wang, Xiaoli
    Mao, Zhi
    Yi, Hongyu
    Zhou, Feihu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 1013 - 1022
  • [34] Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis
    Park, Byung Hoon
    Kang, Young Ae
    Park, Moo Suk
    Jung, Won Jai
    Lee, Su Hwan
    Lee, Sang Kook
    Kim, Song Yee
    Kim, Se Kyu
    Chang, Joon
    Jung, Ji Ye
    Kim, Young Sam
    BMC INFECTIOUS DISEASES, 2011, 11
  • [35] The cancer control status and APACHE II score are prognostic factors for critically ill patients with cancer and sepsis
    Kuo, Wei-Ke
    Hua, Chung-Ching
    Yu, Chung-Chieh
    Liu, Yu-Chih
    Huang, Chih-Yu
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 276 - 281
  • [36] Lactate in the critically ill patients: an outcome marker with the times
    Nguyen, H. Bryant
    CRITICAL CARE, 2011, 15 (06):
  • [37] Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients
    Kopterides, P.
    Tsangaris, I.
    MINERVA ANESTESIOLOGICA, 2012, 78 (07) : 823 - 835
  • [38] Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile
    Tsirigotis, Panagiotis
    Chondropoulos, Spiros
    Frantzeskaki, Frantzeska
    Stamouli, Maria
    Gkirkas, Konstantinos
    Bartzeliotou, Anastasia
    Papanikolaou, Nikolaos
    Atta, Maria
    Papassotiriou, Ioannis
    Dimitriadis, George
    Dimopoulou, Ioanna
    JOURNAL OF CRITICAL CARE, 2016, 32 : 9 - 15
  • [39] Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome
    Brodska, Helena
    Valenta, Jiri
    Pelinkova, Kveta
    Stach, Zdenek
    Sachl, Robert
    Balik, Martin
    Zima, Tomas
    Drabek, Tomas
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (04) : 658 - 668
  • [40] Bayesian approach to control of amikacin serum concentrations in critically ill patients with sepsis
    Lugo-Goytia, G
    Castañeda-Hernández, G
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (12) : 1389 - 1394